FFilingSight

Mosaic Co. (MOS) 10-K Red Flags

Risk signals extracted deterministically from Mosaic Co.’s SEC 10-K/10-Q XBRL filings — no LLM, every finding cites the underlying data.

Detected red flags (21)

  • Inventory buildup exceeds sales growth: Inventory grew +1.0% vs revenue -28.4%. Excess inventory may signal weakening demand, potential write-downs, or supply chain overcommitment. Watch gross margin for discounting impact.
  • Leverage is building — debt rising while equity contracts: Long-term debt grew +26.9% while stockholders equity declined -6.6%. The debt-to-equity ratio is deteriorating, increasing financial risk and interest burden. This may constrain future borrowing capacity.
  • Gross margin compression: Gross margin contracted +14.0%pp (from 30.1% to 16.1%). This may reflect input cost inflation, pricing pressure, or product mix shift toward lower-margin segments.
  • Free cash flow deteriorating: FCF declined +62.6% YoY (from $2.69B to $1.00B). With OCF at $2.41B and capex at $1.40B, cash generation capacity is weakening — monitor for dividend/buyback sustainability.
  • NEW: Going concern doubt in latest filing: The term "going concern" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 13 filing(s).
  • Material weakness in internal controls: The term "material weakness" appears in 31 recent filing(s) (vs 2 in the prior period). This risk language is ongoing.
  • Endogenous analysis: Gross margin compression combined with rising leverage creates a compounding effect: lower margins reduce operating cash flow exactly when higher debt demands more interest coverage. This dual pressure can trigger a negative feedback loop if not addressed.
  • Endogenous analysis: Free cash flow declined despite stable or rising capex, indicating the cash burn is operational rather than investment-driven. This is a structural concern — cost reduction or asset sales may be needed to restore FCF.
  • Endogenous analysis: Inventory accumulation alongside margin compression is a classic demand-softening signal: excess inventory typically leads to discounting, which compresses margins further. Monitor for clearance events, write-downs, or guidance revisions.
  • 11 new XBRL disclosure(s) in latest filing — expanding reporting scope.
  • 20 disclosure(s) dropped from prior year — reduced reporting granularity.
  • 2 new risk-language term(s) detected in filing text: Going concern doubt, Restatement of financial statements.
  • Ongoing high-severity risk language: Material weakness in internal controls.
  • Revenue declined **+28.4%** YoY to $13.70B.
  • Net margin at **8.51%** (expanding ▲).
  • Price $21.13 — downtrend (below 200-DMA); 1-month momentum negative.
  • RSI(14) 50.22.
  • Composite risk: Elevated.
  • Leverage debt/equity 0.32 (low).
  • Inventory buildup exceeds sales growth: Inventory grew +1.0% vs revenue -28.4%. Excess inventory may signal weakening demand, potential write-downs, or supply chain overcommitment. Watch gross margin for discounting impact.
  • Leverage is building — debt rising while equity contracts: Long-term debt grew +26.9% while stockholders equity declined -6.6%. The debt-to-equity ratio is deteriorating, increasing financial risk and interest burden. This may constrain future borrowing capacity.

Filings & ownership

  • Latest annual report (10-K) filed Feb 27, 2026.
  • Latest quarterly report (10-Q) filed May 11, 2026.
  • 19 recent 8-K material-event filings in the index.
  • Recent insider Form 4s: 0 buy vs 0 sell transactions.
  • ~10,000+ recent 13F-HR filings reference Mosaic Co.; broad institutional reporting.
  • Recent filers include TIDE POINT CAPITAL MANAGEMENT, LP, SOUND ENERGY PARTNERS, INC., CRITERIA CAIXA, S.A.U..
  • 20 recent 13G passive institutional ownership notices.

Full MOS analyst report

Valuation (DCF & Graham), technicals, macro exposure, risk scorecard and 13F/13D ownership.

View full report →

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.